DLEU2 facilitates bladder cancer progression through miR-103a-2-5p/SOS1 axis
PeerJ · 2025
DOI: 10.7717/peerj.18995 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Yinlong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China. Hauptthemen laut MEDLINE: MicroRNAs, Urinary Bladder Neoplasms, RNA, Long Noncoding, SOS1 Protein. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bladder cancer (BC) represents a life-threatening malignancy within the urinary system. Dysregulated long non-coding RNAs (lncRNAs) play pivotal roles in the advancement of BC. LncRNA deleted in lymphocytic leukemia 2 (DLEU2) is implicated in the development of various cancers. However, its role and regulatory mechanisms in BC remain unclear. This research aimed to explore the expression, biological function, and molecular mechanisms of DLEU2 In BC progression.
Methods
Expression profiles of lncRNAs, microRNAs (miRNAs), and mRNAs in normal and BC tissues were examined by leveraging the raw data sourced from the NCBI GEO database. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) validated expression levels in BC cells. To evaluate the proliferation and migration capabilities of BC cells, assays such as CCK-8, EdU, Transwell, and scratch were carried out. Luciferase reporter assays examined interactions between DLEU2 and miR-103a-2-5p and between miR-103a-2-5p with SOS1 . Protein expression of SOS1 in BC cells was analyzed via western blotting.
Results
DLEU2 was markedly increased in BC tissues. Functionally, DLEU2 overexpression elevated BC cell proliferation and migration, while its knockdown produced the opposite effects. Mechanistically, DLEU2 acted as a molecular sponge for miR-103a-2-5p, which targeted SOS1 . miR-103a-2-5p knockdown enhanced proliferation and migration, while co-knockdown of miR-103a-2-5p and DLEU2 reversed these effects. Overexpression of SOS1 also promoted proliferation and migration, which were counteracted by miR-103a-2-5p overexpression. Conversely, SOS1 knockdown inhibited these processes, with miR-103a-2-5p knockdown reversing this inhibition.
Conclusions
These findings demonstrate that DLEU2 facilitates BC progression via the miR-103a-2-5p/SOS1 axis. This study reveals a novel regulatory mechanism underlying BC development and highlights DLEU2 as a potential therapeutic target for BC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
- Department of Medical Oncology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
- Department of Clinical Pharmacy, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Zitieren
APA
Liu, Y., Hu, J., Liao, B., Zhu, Z., Liu, Y., & Pan, Q. (2025). DLEU2 facilitates bladder cancer progression through miR-103a-2-5p/SOS1 axis. PeerJ. https://doi.org/10.7717/peerj.18995
Vancouver
Liu Y, Hu J, Liao B, Zhu Z, Liu Y, Pan Q. DLEU2 facilitates bladder cancer progression through miR-103a-2-5p/SOS1 axis. PeerJ. 2025. doi:10.7717/peerj.18995
BibTeX
@article{Liu2025,
author = {Liu, Yinlong and Hu, Jian and Liao, Baochun and Zhu, Zhijian and Liu, Yong and Pan, Qinghua},
title = {DLEU2 facilitates bladder cancer progression through miR-103a-2-5p/SOS1 axis},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.18995}
}
EUVIMED